Matches in SemOpenAlex for { <https://semopenalex.org/work/W130577897> ?p ?o ?g. }
- W130577897 abstract "Lobjectiu daquesta tesi va ser obtenir nous coneixements sobre la immunologia i epidemiologia de la infeccio per Leishmania en gossos que viuen en zones endemiques.El capitol 2 descriu lexpressio danticossos anti-Leishmania IgG, IgG1 i IgG2 en una poblacio de gossos. Els nivells dimmunoglobulines en gossos asimptomatics van ser molt variables i menors que els dels animals malalts. En els animals malalts, els nivells de IgG i IgG2 van ser molt alts pero els nivells d IgG1 molt variables. Els resultats van mostrar la gran variacio en lexpressio de IgG1 tant en gossos asimptomatics com en simptomatics, aixi com la baixa correlacio de la IgG1 amb la IgG o IgG2.El capitol 3 descriu lavaluacio i comparacio de leficacia de dues preparacions de leishmanines en la deteccio de la resposta cel·lular davant de Leishmania en el gos.El capitol 4 mostra lestudi de la resposta humoral i cel·lular en una poblacio de gossos. El 77% dels gossos va mostrar una resposta immunitaria especifica davant de Leishmania, ja fos humoral o cel·lular. El 80% dels cans eivissencs i el 48% dels gossos daltres races van presentar resposta cel·lular. Els resultats van mostrar que la taxa dinfeccio era molt alta, i que els gossos presentaven un ampli ventall de respostes inmunitaries, des de gossos resistents fins a gossos malalts. El ca eivissenc va manifestar mes uniformement resposta cel·lular.El capitol 5 descriu lestudi de la prevalenca de la malaltia, la seroprevalenca i la prevalenca de la infeccio. Es va analitzar el quadre clinic, la serologia i la presencia dADN de Leishmania en diferents teixits. La prevalenca de la malaltia i seroprevalenca van ser, respectivament, dun 13% i dun 26%. Els resultats de PCR positives en moll dos, conjuntiva i pell van ser respectivament, dun 18%, 32% i 51%. La prevalenca de la infeccio va ser dun 67%. La majoria de gossos de zona endemica ha estat infectat pel parasit.El capitol 6 descriu lestudi de parametres immunologics (serologia, test intradermic amb leishmanina, assaig de proliferacio de limfocits i deteccio dIFN-g i TNF-a) en lavaluacio de gossos infectats amb Leishmania. La majoria dels animals infectats sense simptomatologia clinica presentava nivells variables danticossos, reaccio positiva al test intradermic, bona resposta proliferativa al antigen de Leishmania i produccio dIFN-g. La resta va mostrar nivells variables danticossos pero absencia de reaccio al test intradermic. Abans del tractament, els animals malalts presentaven alts nivells danticossos, test intradermic negatiu, no produccio dIFN-g i produccio de TNF-a. La millora clinica es va associar amb la disminucio dels anticossos i amb laugment del diametre del test intradermic. La combinacio de la serologia, el test intradermic i la medicio de citocines constitueixen tecniques utils i dalta rellevancia clinica en lavaluacio de la resposta inmunitaria dun pacient individual.The objective of this thesis was to obtain new knowledge about the immunology and epidemiology of Leishmania infection in dogs living in endemic regions in the Mediterranean basin.Chapter 2 describes the expression of IgG, IgG1 and IgG2 specific antibodies to L. infantum in a wide population of dogs. The levels of immunoglobulins in asymptomatic dogs were highly variable and lower than those found in ill dogs. In ill dogs, the levels of IgG and IgG2 were very high but the levels of IgG1 were extremely variable. Overall results showed a large variation in the IgG1 expression in asymptomatic and symptomatic dogs and a low IgG1 correlation with IgG or IgG2.Chapter 3 describes the evaluation and comparison of the efficacy of two leishmanins for detection dog Leishmania cellular immune response.Chapter 4 describes the study of humoral and cellular responses in a population of dogs. Seventy-seven percent of the dogs demonstrated a specific Leishmania response either humoral or cellular. Eighty percent of ibizian hounds and 48% of dogs of other breeds presented a cellular response. The results showed that the rate of infection was high and that dogs presented a broad range of immune responses from resistant to ill dogs. The Ibizian hound manifested a more uniform cellular response.Chapter 5 describes the study of the prevalence of Leishmania infection, the seroprevalence and the prevalence of canine leishmaniosis. Clinical exploration for the presence of clinical signs compatible with leishmaniosis, the titre of anti-Leishmania antibodies, and the presence of Leishmania DNA by PCR on several tissues were assessed. The prevalence of the disease was 13% and the seroprevalence was 26%. The results of positive PCR in the bone marrow, the conjunctiva and the skin were 18%, 32% and 51%, respectively. The prevalence of the infection was 67%. The results showed that Leishmania infects the majority of dogs living in an endemic area.Chapter 6 describes the study of immunological parameters (anti-Leishmania IgG1, IgG2, total IgG antibodies, LST, LPA, and production of IFN-g and TNF-a) in the evaluation of dogs infected by Leishmania. The majority of infected animals without clinically patent disease showed variable titres of anti-Leishmania antibodies, a positive LST, a strong Leishmania antigenic proliferative response, and a high production of IFN-g. The remainder showed positive titres of anti-Leishmania antibodies with a negative positive LST. Before treatment, ill dogs presented high levels of anti-Leishmania antibodies, negative LST, no production of IFN-g but a production of TNF-a. Clinical recovery was associated with a decrease in the titre of antibodies and an increase of the diameter of the LST. The combination of serology, LST, and measurement of cytokines constitutes a useful, clinically relevant method to evaluate the immune response to Leishmania in a single patient." @default.
- W130577897 created "2016-06-24" @default.
- W130577897 creator A5029325073 @default.
- W130577897 date "2001-05-04" @default.
- W130577897 modified "2023-09-28" @default.
- W130577897 title "Leishmania infantum and dog: immunological and epidemiological studies about infection and disease" @default.
- W130577897 cites W108890572 @default.
- W130577897 cites W1222538688 @default.
- W130577897 cites W137314869 @default.
- W130577897 cites W151941690 @default.
- W130577897 cites W1530190253 @default.
- W130577897 cites W1546027157 @default.
- W130577897 cites W1555734844 @default.
- W130577897 cites W1558587709 @default.
- W130577897 cites W1566108832 @default.
- W130577897 cites W163825031 @default.
- W130577897 cites W1672786836 @default.
- W130577897 cites W1835042769 @default.
- W130577897 cites W1855001688 @default.
- W130577897 cites W1898965321 @default.
- W130577897 cites W1926920634 @default.
- W130577897 cites W1964362811 @default.
- W130577897 cites W1965279147 @default.
- W130577897 cites W1966805047 @default.
- W130577897 cites W1966932913 @default.
- W130577897 cites W1969819979 @default.
- W130577897 cites W1974051529 @default.
- W130577897 cites W1974504941 @default.
- W130577897 cites W1975967822 @default.
- W130577897 cites W1976986439 @default.
- W130577897 cites W1978426883 @default.
- W130577897 cites W1978869673 @default.
- W130577897 cites W1978978959 @default.
- W130577897 cites W1979254253 @default.
- W130577897 cites W1983017688 @default.
- W130577897 cites W1984953616 @default.
- W130577897 cites W1986161474 @default.
- W130577897 cites W1989278893 @default.
- W130577897 cites W1991664885 @default.
- W130577897 cites W1994412261 @default.
- W130577897 cites W1994985963 @default.
- W130577897 cites W1995491273 @default.
- W130577897 cites W1999526781 @default.
- W130577897 cites W2000719201 @default.
- W130577897 cites W2001933724 @default.
- W130577897 cites W2003344022 @default.
- W130577897 cites W2007165619 @default.
- W130577897 cites W2008868979 @default.
- W130577897 cites W2010657426 @default.
- W130577897 cites W2010696604 @default.
- W130577897 cites W2013805878 @default.
- W130577897 cites W2014124621 @default.
- W130577897 cites W2019728896 @default.
- W130577897 cites W2021169743 @default.
- W130577897 cites W2023867129 @default.
- W130577897 cites W2028387078 @default.
- W130577897 cites W2028615233 @default.
- W130577897 cites W2031501484 @default.
- W130577897 cites W2031509892 @default.
- W130577897 cites W2032115219 @default.
- W130577897 cites W2032160478 @default.
- W130577897 cites W2033431194 @default.
- W130577897 cites W2035244662 @default.
- W130577897 cites W2037590410 @default.
- W130577897 cites W2040787968 @default.
- W130577897 cites W2043231985 @default.
- W130577897 cites W2047713498 @default.
- W130577897 cites W2050625697 @default.
- W130577897 cites W2051262391 @default.
- W130577897 cites W2051422606 @default.
- W130577897 cites W2055534627 @default.
- W130577897 cites W2056656305 @default.
- W130577897 cites W2059709253 @default.
- W130577897 cites W2059861139 @default.
- W130577897 cites W2060237398 @default.
- W130577897 cites W2061516229 @default.
- W130577897 cites W2066721968 @default.
- W130577897 cites W2066798797 @default.
- W130577897 cites W2070046940 @default.
- W130577897 cites W2070088440 @default.
- W130577897 cites W2070266648 @default.
- W130577897 cites W2072045280 @default.
- W130577897 cites W2074079260 @default.
- W130577897 cites W2079575730 @default.
- W130577897 cites W2080370913 @default.
- W130577897 cites W2082076638 @default.
- W130577897 cites W2082954074 @default.
- W130577897 cites W2083546820 @default.
- W130577897 cites W2083946109 @default.
- W130577897 cites W2084664326 @default.
- W130577897 cites W2084730165 @default.
- W130577897 cites W2087979800 @default.
- W130577897 cites W2088121552 @default.
- W130577897 cites W2088294375 @default.
- W130577897 cites W2088509236 @default.
- W130577897 cites W2089043384 @default.
- W130577897 cites W2090217849 @default.
- W130577897 cites W2092205546 @default.
- W130577897 cites W2092554084 @default.
- W130577897 cites W2094137310 @default.